EGF1-48

N/A

Report date: 2023/10/26 11:13:42

Base Information

Drug NameEGF1-48
Drug Alias NameEGF1-48
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionEpidermal growth factor receptor erbB1 agonists
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsOptic NeuritisPolyradiculoneuropathy, Chronic Inflammatory DemyelinatingGuillain-Barre Syndrome +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCresence AS
China Registration ClassN/A

Develop Information

Active CompaniesBioasis Technologies Inc
Inactive CompaniesN/A
Active IndicationsOptic NeuritisPolyradiculoneuropathy, Chronic Inflammatory DemyelinatingGuillain-Barre Syndrome +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A